Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STN-DBS and Levodopa for Freezing of Gait in Parkinson's Disease
NCT06316232Phase 4Recruiting
- Sponsor
- IRCCS Institute of Neurological Sciences of Bologna
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levodopa in Parkinson's disease (PD), sponsored by IRCCS Institute of Neurological Sciences of Bologna. Started Oct 2023; status: recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06316232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06316232.